Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ANJU VASUDEVAN

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1043203888
CMS profile
1601
Location
OCALA, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$10,729.10

186 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $6,365.00 3
Food and Beverage $4,165.15 181
Education $198.95 2

By paying entity

PY2025 · entire year · sorted by reported total

Paying entityAmountRecords
AstraZeneca Pharmaceuticals LP $6,738.12 15
Novartis Pharmaceuticals Corporation $436.98 24
Celgene Corporation $343.20 13
PFIZER INC. $200.15 9
SEAGEN INC. $198.95 2
GlaxoSmithKline, LLC. $175.58 10
Merck Sharp & Dohme LLC $161.38 8
E.R. Squibb & Sons, L.L.C. $155.84 10
Incyte Corporation $138.46 6
Menarini Silicon Biosystems, Inc. $130.82 2
Genmab U.S., Inc. $125.00 1
Eisai Inc. $124.51 7
Regeneron Healthcare Solutions, Inc. $119.15 4
Daiichi Sankyo Inc. $118.01 6
BeOne Medicines USA, Inc. $104.50 4
Caris MPI, Inc. $101.62 2
EMD Serono, Inc. $81.86 4
Gilead Sciences, Inc. $77.74 3
Fennec Pharmaceuticals, Inc. $77.39 4
Janssen Biotech, Inc. $76.04 4
PharmaEssentia USA Corporation $68.67 3
Lilly USA, LLC $64.05 2
Boehringer Ingelheim Pharmaceuticals, Inc. $62.82 3
ABBVIE INC. $62.38 3
Pharmacosmos Therapeutics Inc. $62.34 2
Legend Biotech USA Inc. $56.02 3
Bayer Healthcare Pharmaceuticals Inc. $48.76 2
Coherus Oncology, Inc. $48.13 3
Astellas Pharma US Inc $39.18 2
Alexion Pharmaceuticals, Inc. $37.68 2
Dendreon Pharmaceuticals LLC $34.90 1
Genentech USA, Inc. $34.70 2
PUMA BIOTECHNOLOGY, INC. $33.68 2
SUN PHARMACEUTICAL INDUSTRIES INC. $32.49 1
SERVIER PHARMACEUTICALS LLC $32.05 2
KYOWA KIRIN, INC. $29.30 1
Novocure Inc. $28.18 1
Corcept Therapeutics $27.74 1
BeiGene USA, Inc. $24.45 1
RECORDATI_RARE_DISEASES_INC. $22.96 1
SpringWorks Therapeutics, Inc. $22.21 1
TAIHO ONCOLOGY, INC. $21.58 1
Geron Corporation $20.35 1
Agios Pharmaceuticals, Inc. $19.50 1
Stemline Therapeutics Inc. $19.20 1
Takeda Pharmaceuticals U.S.A., Inc. $18.73 1
Octapharma USA, Inc. $18.53 1
Adaptive Biotechnologies Corporation $18.47 1
Deciphera Pharmaceuticals Inc. $18.14 1
ARRAY BIOPHARMA INC $16.61 1

Page 2 of 4; records 51–100 of 186 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ANJU VASUDEVAN

NPI 1043203888 · CMS profile ID 1601

Allopathic & Osteopathic Physicians / Internal Medicine / Medical Oncology

OCALA, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 4; records 51–100 of 186 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1043203888?year=2025&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ANJU VASUDEVAN, NPI 1043203888, CMS profile ID 1601. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 186 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1043203888?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). ANJU VASUDEVAN, NPI 1043203888, CMS profile ID 1601. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 186 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1043203888?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
ANJU VASUDEVAN, NPI 1043203888, CMS profile ID 1601, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 4; records 51–100 of 186 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1043203888?year=2025&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

186 matching records · $10,729.10 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 186 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 186.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
AstraZeneca Pharmaceuticals LP $59.5109/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206832022 CMS
Incyte Corporation $15.3009/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226165835 CMS
Incyte Corporation $25.1208/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226158788 CMS
Incyte Corporation $27.9408/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226158794 CMS
Novartis Pharmaceuticals Corporation $0.4108/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200572605 CMS
Novartis Pharmaceuticals Corporation $25.7308/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200572607 CMS
Daiichi Sankyo Inc. $20.1408/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1197020745 CMS
ABBVIE INC. $15.7208/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1204627763 CMS
Novartis Pharmaceuticals Corporation $22.3808/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200572613 CMS
Novartis Pharmaceuticals Corporation $0.7108/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200572615 CMS
Fennec Pharmaceuticals, Inc. $15.0808/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1250856021 CMS
Astellas Pharma US Inc $19.8608/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238641672 CMS
Novartis Pharmaceuticals Corporation $24.0908/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200572593 CMS
Novartis Pharmaceuticals Corporation $2.5608/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200572595 CMS
Celgene Corporation $11.5608/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184841811 CMS
E.R. Squibb & Sons, L.L.C. $0.7708/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184841813 CMS
E.R. Squibb & Sons, L.L.C. $15.0208/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184841815 CMS
GlaxoSmithKline, LLC. $2.9208/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190593079 CMS
GlaxoSmithKline, LLC. $24.0208/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190644505 CMS
Merck Sharp & Dohme LLC $18.9108/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238046483 CMS
Novartis Pharmaceuticals Corporation $26.7607/31/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200572589 CMS
Novartis Pharmaceuticals Corporation $1.0807/31/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200572591 CMS
Caris MPI, Inc. $22.0807/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234288864 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $16.5707/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1222865332 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $21.7607/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1222865341 CMS
BeOne Medicines USA, Inc. $24.8107/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202900432 CMS
E.R. Squibb & Sons, L.L.C. $14.9107/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184841803 CMS
GlaxoSmithKline, LLC. $22.4007/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190746671 CMS
Regeneron Healthcare Solutions, Inc. $35.1107/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1213063662 CMS
Genentech USA, Inc. $17.8807/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1211494136 CMS
E.R. Squibb & Sons, L.L.C. $21.9407/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184841799 CMS
PFIZER INC. $26.8907/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229460094 CMS
SEAGEN INC. $99.9507/03/2025 Education No dispute reported Delay: No
Change: NEW
06/30/2026 1229393373 CMS
Celgene Corporation $35.1407/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184841797 CMS
Daiichi Sankyo Inc. $16.6206/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1197086657 CMS
Novartis Pharmaceuticals Corporation $25.8106/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200572587 CMS
Coherus Oncology, Inc. $17.6106/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1235236841 CMS
PFIZER INC. $16.9006/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229336561 CMS
Celgene Corporation $33.0006/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184841789 CMS
E.R. Squibb & Sons, L.L.C. $15.4606/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184841775 CMS
PFIZER INC. $29.2606/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229354732 CMS
Merck Sharp & Dohme LLC $17.2106/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238195520 CMS
Legend Biotech USA Inc. $19.1606/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1236476954 CMS
Novocure Inc. $28.1806/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251153342 CMS
EMD Serono, Inc. $18.3706/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1236920805 CMS
Deciphera Pharmaceuticals Inc. $18.1406/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1235961749 CMS
ABBVIE INC. $19.7306/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1204627759 CMS
Daiichi Sankyo Inc. $18.4906/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1197082451 CMS
AstraZeneca Pharmaceuticals LP $24.2905/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206449314 CMS
Alexion Pharmaceuticals, Inc. $20.5805/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202948568 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $7,334.59 196
PY2020 $11,730.82 169
PY2021 $8,641.90 207
PY2022 $11,709.39 234
PY2023 $8,827.27 216
PY2024 $5,563.29 224
PY2025 $10,729.10 186

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $615,355.98 6
PY2024 Principal investigator $65,007.80 9
PY2023 Principal investigator $101,468.00 33
PY2022 Principal investigator $71,026.00 44
PY2021 Principal investigator $9,181.40 5
PY2020 Recipient $139.20 1
PY2020 Principal investigator $24,956.00 4
PY2019 Recipient $1,925.67 2
PY2019 Principal investigator $36,438.65 24

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

6 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Novartis Pharmaceuticals Corporation $80.86 11/04/2025 Non-covered Recipient Entity
THE ONCOLOGY RESEARCH INSTITUTE LLC
A Phase IIIb Study to Characterize the Effectiveness and Safety of Adjuvant Ribociclib in a Wide Patient Population With HR+ HER2- Early Breast Cancer (Adjuvant WIDER) No dispute reported 06/30/2026 1190312333
Principal investigator 1 Novartis Pharmaceuticals Corporation $121,062.48 09/04/2025 Non-covered Recipient Entity
THE ONCOLOGY RESEARCH INSTITUTE LLC
A Phase IIIb Study to Characterize the Effectiveness and Safety of Adjuvant Ribociclib in a Wide Patient Population With HR+ HER2- Early Breast Cancer (Adjuvant WIDER) No dispute reported 06/30/2026 1190312335
Principal investigator 1 ABBVIE INC. $40,884.36 05/14/2025 Non-covered Recipient Entity
OCALA ONCOLOGY CENTER PL
A Phase 3 Multicenter Randomized Open-Label Trial to Evaluate Safety and Efficacy of Epcoritamab in Combination with R-CHOP compared to R-CHOP in Subjects with High-Risk Diffuse Large B-Cell Lymphoma No dispute reported 06/30/2026 1202484835
Principal investigator 1 ABBVIE INC. $9,045.00 05/13/2025 Non-covered Recipient Entity
OCALA ONCOLOGY CENTER PL
A Phase 3 Multicenter Randomized Open-Label Trial to Evaluate Safety and Efficacy of Epcoritamab in Combination with R-CHOP compared to R-CHOP in Subjects with High-Risk Diffuse Large B-Cell Lymphoma No dispute reported 06/30/2026 1202484735
Principal investigator 1 ABBVIE INC. $5,000.00 05/07/2025 Non-covered Recipient Entity
OCALA ONCOLOGY CENTER PL
A Phase 3 Multicenter Randomized Open-Label Trial to Evaluate Safety and Efficacy of Epcoritamab in Combination with R-CHOP compared to R-CHOP in Subjects with High-Risk Diffuse Large B-Cell Lymphoma No dispute reported 06/30/2026 1202483379
Principal investigator 1 Novartis Pharmaceuticals Corporation $439,283.28 04/16/2025 Non-covered Recipient Entity
THE ONCOLOGY RESEARCH INSTITUTE LLC
A Phase IIIb Study to Characterize the Effectiveness and Safety of Adjuvant Ribociclib in a Wide Patient Population With HR+ HER2- Early Breast Cancer (Adjuvant WIDER) No dispute reported 06/30/2026 1190312337

Ownership and Investment Interests

One row per program year and measure, newest year first · the amount invested and the value of the interest are never added together

Program yearMeasureAmountRecords
PY2022 Amount invested $0.00 1
PY2022 Value of interest $119,000.00 1
PY2021 Amount invested $0.00 1
PY2021 Value of interest $92,200.00 1
PY2020 Amount invested $0.00 1
PY2020 Value of interest $90,000.00 1
PY2019 Amount invested $0.00 1
PY2019 Value of interest $135,000.00 1

Ownership and Investment Interests are a separate CMS dataset, shown here separately and never added to payments.

Ownership and investment interests are reported as the value of an interest held, not as a payment received. They are a different measure from the payment total on this page and are never combined with it.

Ownership and Investment Interests records

Ordering applied by this site (program year, newest first, then company) · record values are shown as CMS published them

4 records · PY2019–2022

Ownership and Investment Interests records (CSV)

Program yearCompanyAmount invested Value of interestTerms of interestInterest held by Dispute statusPublishedRecord ID
PY2022 Innovation Technologies Inc $0.00 $119,000.00 Common Shares Physician Covered Recipient No dispute reported 06/30/2026 954225435
PY2021 Innovation Technologies Inc $0.00 $92,200.00 Common Shares Physician Covered Recipient No dispute reported 06/30/2026 849647691
PY2020 Innovation Technologies Inc $0.00 $90,000.00 Common Shares Physician Covered Recipient No dispute reported 06/30/2026 749849307
PY2019 Innovation Technologies Inc $0.00 $135,000.00 Common Shares Physician Covered Recipient No dispute reported 06/30/2026 694466579